By combining the molecular manipulation of GBM cells, single-cell sequencing, computational analyses, and tumor-immune cell co-culture systems, we identify a novel TGFBR2-driven phenotype in GSCs with molecular parallels to regulatory T cell (Treg) fate induction. Here, TGFBR2 is linked to glioblastoma.